๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
491 results for โ€œNovoโ€
MedicineActive substanceLicence holderStatus
Vardenafil Krka 10 mg film-coated tablets
PA1347/073/002
VARDENAFIL HYDROCHLORIDE TRIHYDRATE KRKA, d.d., Novo mesto Not marketed
Vardenafil Krka 20 mg film-coated tablets
PA1347/073/003
VARDENAFIL HYDROCHLORIDE TRIHYDRATE KRKA, d.d., Novo mesto Not marketed
Vardenafil Krka 5mg film-coated tablets
PA1347/073/001
VARDENAFIL HYDROCHLORIDE TRIHYDRATE KRKA, d.d., Novo mesto Not marketed
Venlafex XL 150 mg prolonged-release capsules, hard
PA1347/036/003
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Venlafex XL 37.5 mg prolonged-release capsules, hard
PA1347/036/001
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Venlafex XL 75 mg prolonged-release capsules, hard
PA1347/036/002
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Victoza 6 mg/ml solution for injection in pre-filled pen
EU/1/09/529/1-5
Liraglutide Novo Nordisk A/S โ€”
Vildagliptin Krka 50 mg tablets
PA1347/076/001
Vildagliptin KRKA, d.d., Novo mesto Not marketed
Vizarsin 100 mg film-coated tablets
EU/1/09/551/9-12
Sildenafil KRKA, d.d., Novo mesto โ€”
Vizarsin 100 mg orodispersible tablets
EU/1/09/551/023-027
Sildenafil KRKA, d.d., Novo mesto โ€”
Vizarsin 25 mg film-coated tablets
EU/1/09/551/1-4
Sildenafil KRKA, d.d., Novo mesto โ€”
Vizarsin 25 mg orodispersible tablets
EU/1/09/551/013-017
Sildenafil KRKA, d.d., Novo mesto โ€”
Vizarsin 50 mg film-coated tablets
EU/1/09/551/5-8
Sildenafil KRKA, d.d., Novo mesto โ€”
Vizarsin 50 mg orodispersible tablets
EU/1/09/551/018-022
Sildenafil KRKA, d.d., Novo mesto โ€”
Vortioxetine Krka 10 mg film-coated tablets
PA1347/121/002
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Vortioxetine Krka 15 mg film-coated tablets
PA1347/121/003
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Vortioxetine Krka 20 mg film-coated tablets
PA1347/121/004
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Vortioxetine Krka 5 mg film-coated tablets
PA1347/121/001
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Wegovy 0.25 mg Solution for injection
EU/1/21/1608/001
Semaglutide Novo Nordisk A/S โ€”
Wegovy 0.25 mg Solution for injection
EU/1/21/1608/006
Semaglutide Novo Nordisk A/S โ€”
Wegovy 0.5 mg Solution for injection
EU/1/21/1608/002
Semaglutide Novo Nordisk A/S โ€”
Wegovy 0.5 mg Solution for injection
EU/1/21/1608/007/012
Semaglutide Novo Nordisk A/S โ€”
Wegovy 1 mg Solution for injection
EU/1/21/1608/003
Semaglutide Novo Nordisk A/S โ€”
Wegovy 1 mg Solution for injection
EU/1/21/1608/008
Semaglutide Novo Nordisk A/S โ€”
Wegovy 1.7 mg Solution for injection
EU/1/21/1608/004
Semaglutide Novo Nordisk A/S โ€”
Wegovy 1.7 mg Solution for injection
EU/1/21/1608/009
Semaglutide Novo Nordisk A/S โ€”
Wegovy 2.4 mg Solution for injection
EU/1/21/1608/005
Semaglutide Novo Nordisk A/S โ€”
Wegovy 2.4 mg Solution for injection
EU/1/21/1608/010-011
Semaglutide Novo Nordisk A/S โ€”
Xultophy 100 units/mL + 3.6 mg/mL solution for injection.
EU/1/14/947/001-004
Insulin degludec, Liraglutide Novo Nordisk A/S โ€”
Zalasta 10 mg Orodispersible tablet
EU/1/07/415/42-46
Olanzapine KRKA, d.d., Novo mesto โ€”
Zalasta 10 mg Tablet
EU/1/07/415/16-21
Olanzapine KRKA, d.d., Novo mesto โ€”
Zalasta 15 mg Orodispersible tablet
EU/1/07/415/47-51
Olanzapine KRKA, d.d., Novo mesto โ€”
Zalasta 15 mg Tablet
EU/1/07/415/22-26
Olanzapine KRKA, d.d., Novo mesto โ€”
Zalasta 2.5 mg Tablet
EU/1/07/415/1-5
Olanzapine KRKA, d.d., Novo mesto โ€”
Zalasta 20 mg Orodispersible tablet
EU/1/07/415/52-56
Olanzapine KRKA, d.d., Novo mesto โ€”
Zalasta 20 mg Tablet
EU/1/07/415/27-31
Olanzapine KRKA, d.d., Novo mesto โ€”
Zalasta 5 mg Orodispersible tablet
EU/1/07/415/32-36
Olanzapine KRKA, d.d., Novo mesto โ€”
Zalasta 5 mg Tablet
EU/1/07/415/006
Olanzapine KRKA, d.d., Novo mesto โ€”
Zalasta 7.5 mg Orodispersible tablet
EU/1/07/415/37-41
Olanzapine KRKA, d.d., Novo mesto โ€”
Zalasta 7.5 mg Tablet
EU/1/07/415/11-15
Olanzapine KRKA, d.d., Novo mesto โ€”
Zyllt 75 mg film-coated tablets
EU/1/09/553/001-10
Clopidogrel hydrogensulfate KRKA, d.d., Novo mesto โ€”
โ† 7 8 9 10

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.